Prof. Shaozhong Wei 魏少忠
Chief Physician, Professor
Department of Urologic Surgery, Hubei Cancer Hospital, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of colorectal cancer, gastrointestinal stromal tumors, prostate cancer, kidney cancer, and bladder cancer.
Dr. Wei is President of Hubei Cancer Hospital, a Professor, and a Chief Physician. Holding a medical doctorate, Dr. Wei was a visiting scholar at MD Anderson Cancer Center in the US. Dr. Wei leads provincial research projects, has published over 20 papers, and serves as a master's supervisor.
Professional roles
- Standing Committee Member, Oncology Branch, Chinese Medical Association
- Executive Director, China Anti-Cancer Association
- Editor-in-Chief, Tumor Prevention and Research
- Chair, Oncology Branch, Hubei Medical Association
Name order: in Chinese the family name comes first (Wei Shaozhong). Papers usually list the name as Shaozhong Wei or Wei S.
Selected publications
55 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Curr Issues Mol Biol, 2026 (senior author): Coordinated Expression of ADC Targets ERBB2, TACSTD2, and NECTIN4 in Bladder Cancer: A Multi-Scale Transcriptomic and Proteomic Landscape Analysis. PubMed 42651823
- Int J Surg, 2026 (senior author): RUNX3+ basal-like malignant cells: architects of an immunosuppressive microenvironment in bladder cancer: a comprehensive bioinformatics analysis of single-cell and spatial transcriptomics. PubMed 42682391
- Front Endocrinol (Lausanne), 2025 (senior author): Development and validation of a nomogram for predicting suicide risk factors in thyroid cancer patients following diagnosis: a population-based retrospective study. PubMed 41098581
- Gen Hosp Psychiatry, 2024 (senior author): Association between depressive symptoms and second primary cancer in cancer survivors: Insights from a nationally representative study. PubMed 39197229
- J Affect Disord, 2024 (senior author): Suicide among lymphoma patients. PubMed 38821367
- Heliyon, 2024 (senior author): Whole transcriptome sequencing identifies a competitive endogenous RNA network that regulates the immunity of bladder cancer. PubMed 38681584
- Mol Biol Rep, 2022 (senior author): Deltex E3 ubiquitin ligase 3 inhibits colorectal cancer cell growth and regulates cell cycle progression via upregulating E2F transcription factor 1. PubMed 35098394
- Front Mol Biosci, 2021 (senior author): Creation of a Novel Nomogram Based on the Direct Bilirubin-To-Indirect Bilirubin Ratio and Lactate Dehydrogenase Levels in Resectable Colorectal Cancer. PubMed 34746234
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion